Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Oil, Gold Stocks Boost UK Shares Ahead Of Fed

Wed, 28th Oct 2015 16:51

LONDON (Alliance News) - UK main stock indices ended up Wednesday, with gold miners and oil-related stocks pushing higher, and also boosted by a positive open in the US ahead of the US Federal Reserve's monetary policy decision due at 1800 GMT.

The FTSE 100 index closed up 1.1% at 6,437.80 points, while the FTSE 250 rose 0.6% at 17,143.95 and the AIM All-Share ended down 0.1% at 742.29. European major indices also finished higher, with the CAC 40 index in Paris up 1.0% and the DAX 30 in Frankfurt up 1.4%.

Stocks in Europe were spurred by the gains seen in the US. At the London close, the Dow 30 was up 0.6%, the S&P 500w was up 0.7%, and the Nasdaq Composite was up 0.8%.

Shares in US technology giants Apple and Twitter were trading in opposite directions, after both companies reported results Tuesday after the US market close.

Apple was up 2.6% after it said it raked in USD11.1 billion in net profit in the fourth quarter, thanks to the world's continuing appetite for the iPhone. Apple sold 48 million iPhones worldwide in the fourth quarter, a 22% increase on sales in the same quarter in 2014. The quarter reflects initial sales of the iPhone 6s and 6s Plus, the new model that the California-based company introduced in September.

Twitter's third quarter financial results beat expectations, but its shares were down 3.7% as stagnant user growth and a weak forecast showed the microblog's new chief executive may not have a magic bullet for the company's woes.

The US earnings season continues Wednesday with third-quarter results from online payment system company Paypal expected after the European market close.

Fawad Razaqzada, analyst at FOREX.com said that, though the Fed is likely to leave rates unchanged at 0-0.25% at its Wednesday's meeting, there is a risk that it will deliver a more dovish message, following the recent softness in US economic data and the European Central Bank's "unexpectedly dovish" press conference last week.

"This would signal to the market that the Fed may delay raising rates until at least the first quarter of 2016, leading to a sharp drop in the US dollar and a rally in buck-denominated assets like gold and silver," said Razaqzada. "After all, the Fed will not want the US dollar to appreciate significantly more against the euro than it already has."

However, the analyst believes that if the Fed shows some sign that a 2015 "lift-off" is still on the cards at the December meeting, then the dollar would likely remain supported.

Ahead of the Fed decision, the pound was higher against the greenback at USD1.5320, having touched a low of USD1.5276 earlier in the day. The euro was slightly higher against the dollar at USD1.1071, recovering from an intraday low of USD1,1025.

Crude oil prices rose sharply after data from the US Energy Information Administration showed that crude stockpiles in the US increased less than expected in the week ended October 23. The report said US crude oil inventories lifted by 3.37 million barrels last week, with economists expecting an increase of 3.41 million barrels. The data comes after a previous reading for the week to October 16 which showed a rise of 8.0 million barrels.

At the London close, Brent Oil price was at USD48.96 a barrel, having touched a low of USD46.59 a barrel earlier in the day. Meanwhile, West Texas Intermediate was at USD45.69 a barrel, after touching an intraday low of USD43.05 a barrel.

As a result, shares in UK oil-related companies were in demand, with BP ending up 2.9%, Royal Dutch Shell 'A' up 1.7% and BG Group up 0.7%. Mid-caps Premier Oil and Tullow Oil also were in favour, up 7.5% and 6.8%, respectively. Shell is expected to release its third-quarter results on Thursday before the market open.

Gold miners Fresnillo, up 4.6%, and Randgold Resources, up 3.8%, benefited from a rise in the metal price. At the London close, Gold was at USD1,178.78 an ounce, rising from an intraday low of USD1,165.20 an ounce.

Outside commodities, GlaxoSmithKline ended up 3.9%. A strong performance from its vaccines franchise helped the drugmaker to outpace market expectations for the third quarter. The group reiterated its guidance for 2015 and indicated a positive outlook for 2016.

The FTSE-100 listed pharmaceutical giant reported a pretax profit of GBP867 million for the quarter to end-September, up from GBP548 million a year before, as revenue rose to GBP6.13 billion from GBP5.65 billion. Revenue in the quarter to the end of September was driven by 32% growth in vaccines and 55% growth in consumer health, which offset a decline of 7% in the company's pharmaceuticals business.

Peers Hikma Pharmaceuticals and Astrazeneca also ended in the green, up 3.3% and 2.6%, respectively.

BT Group finished up 3.7% after the company said the UK Competition and Markets Authority has provisionally cleared its proposed GBP12.5 billion acquisition of mobile operator EE. The clearance from the UK antitrust regulator has been given without any remedies required to gain approval.

The CMA said it has provisionally decided the deal "is not expected to result in a substantial lessening of competition in any market in the UK". BT said this includes the supply of retail mobile, wholesale mobile, mobile backhaul, wholesale broadband and retail fixed broadband services. BT is due to release its half-year results on Thursday.

At the other end of the index, aerospace and defence components manufacturer Meggitt took a hit, down 23%, after issuing a profit warning. The group said trading in the third quarter of 2015 had been below its expectations, with little optimism for any relief in the fourth quarter.

Meggitt said there was a "marked deterioration" in trading in September, with organic growth in its civil original equipment sales more than offset by weaker-than-anticipated trading in the civil aftermarket, military and particularly energy markets, the latter hit hard by the downturn in spending from oil and gas customers.

In the FTSE 250, Petra Diamonds ended down 10%, even though the diamond miner said production reached record levels in the first quarter of the financial year and the weakening of the South African rand is mitigating the steep fall in diamond prices. Although production has reached record levels, the company did not book any revenue in the first quarter of 2015, compared to USD100.8 million a year earlier.

Elsewhere on the UK corporate calendar Thursday, Barclays and Aviva issue third-quarter interim management statements, while Smith & Nephew releases third-quarter results. Playtech and Henderson Group issue a third-quarter trading statements, and Kaz Minerals and National Express Group publish third-quarter interim Management statements.

In the economic calendar, UK Nationwide housing prices are due at 0700 GMT, while UK mortgage approvals and consumer credit data are expected at 0930 GMT. Eurozone economic sentiment indicator is due at 1000 GMT. Germany's consumer price index is due at 1300 GMT.

In the US, Initial jobless claims are due at 1230 GMT, alongside the third-quarter reading of US gross domestic product. Pending home sales are due at 1400 GMT, while EIA Natural gas storage data is at 1430 GMT.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.